| Patents for C12R 1 - Micro-organisms (92,025) |
|---|
| 03/20/2001 | US6204045 Genetically engineered infectious laryngotracheitis virus; for the development of vaccines against viral disease |
| 03/20/2001 | US6204042 Isolated polynucleotide segment |
| 03/20/2001 | US6204032 Method for producing pravastatin precursor, ML-236B |
| 03/20/2001 | US6204015 Aminopeptidase from staphylococcus aureus |
| 03/20/2001 | US6204012 Protein production process |
| 03/20/2001 | US6204011 Human receptor tyrosine kinase, KDR |
| 03/20/2001 | US6203998 Human dopamine receptor and its uses |
| 03/20/2001 | US6203800 Screening for antibacterial agents; genetic engineering |
| 03/20/2001 | CA2033657C Glucose isomerases having altered substrate specificity |
| 03/15/2001 | WO2001018226A1 Method for producing exopolysaccharides |
| 03/15/2001 | WO2001018195A2 Luciferase expression cassettes and methods of use |
| 03/15/2001 | WO2001018185A1 High level cytokine production with enhanced cell viability |
| 03/15/2001 | WO2001018175A1 Method for producing a heterologous secreted protein from chinese hamster ovary cells grown on microcarriers |
| 03/15/2001 | WO2001017553A1 Equine herpes virus temperature sensitive mutant and live vaccine thereof |
| 03/15/2001 | WO2000070037A3 Directed evolution of microorganisms |
| 03/15/2001 | WO2000066732A3 Laminin 8 and methods for its use |
| 03/15/2001 | WO2000066711A3 Streptococcus gordonii strains resistant to fluorodeoxyuridine |
| 03/15/2001 | WO1999054454A9 Mutants of the mycobacterium species and use of the same for screening for antibiotics vectors |
| 03/15/2001 | DE19943587A1 Neue für das dapF-Gen codierende Nukleotidsequenzen New coding for the dapF gene nucleotide sequences |
| 03/15/2001 | CA2384496A1 Luciferase expression cassettes and methods of use |
| 03/15/2001 | CA2383980A1 Equine herpes virus temperature sensitive mutant and live vaccine thereof |
| 03/15/2001 | CA2383767A1 Method for producing a heterologous secreted protein from chinese hamster ovary cells grown on microcarriers |
| 03/15/2001 | CA2383563A1 High level cytokine production with enhanced cell viability |
| 03/15/2001 | CA2318507A1 Novel nucleotide sequences coding for the pgi gene |
| 03/14/2001 | EP1083234A1 Process for producing l-ribose |
| 03/14/2001 | EP1083233A1 Production of natural flavors by laccase catalysis |
| 03/14/2001 | EP1083230A1 Viral replicons and viruses dependent on inducing agents |
| 03/14/2001 | EP1083225A1 Method for the fermentative production of D-pantothenic acid using coryneform bacteria |
| 03/14/2001 | EP1082455A1 Primers for the detection of spore forming bacteria in paper products and paper manufacturing streams |
| 03/14/2001 | EP1082448A1 Improved process for alcoholic fermentation |
| 03/14/2001 | EP1082441A1 Mycobacterial n-acetyltransferases |
| 03/14/2001 | EP1082431A2 Protease inhibitor peptides |
| 03/14/2001 | EP1082421A2 Human bmp-2 promoter and method for exploring bone-related substance by using the same |
| 03/14/2001 | EP1082404A2 Multiply-substituted protease variant and amylase variant-containing cleaning compositions |
| 03/14/2001 | EP1082021A1 Process for the manufacture of probiotic cheese |
| 03/14/2001 | EP0804601B1 Genetic therapy of tumours with an endothelium cell-specific active substance which is dependent on the cell cycle |
| 03/14/2001 | EP0671472B1 Anti-feline herpesvirus-1 recombinant antibody and gene fragment coding for said antibody |
| 03/13/2001 | US6201115 Amplifying sequences, vectors comprising these sequences and their uses in compositions for the expression of nucleotide sequences in transfected cells therapeutic and vaccine applications |
| 03/13/2001 | US6201108 Antibodies which bind to mammalian transforming growth factor-beta type ii receptor; treatment of bone disorders; anticarcinogenic/antimetastasis agents |
| 03/13/2001 | US6201105 Amino acid sequence; treatment of septic shock and cachexia; diagnosis |
| 03/13/2001 | US6201005 Method for inhibiting lymphokine production |
| 03/13/2001 | US6200813 Altering substrate specificity of polyketide synthase by isolating genomic dna fragments which encode acyltransferase domain, transforming cell having one fragment with other fragment for homologous recombination; antibiotics |
| 03/13/2001 | US6200800 Defective moloney murine leukemia provirus used as retroviral vector for gene therapy and vaccines; has recognition sequence for elimination of proviral sequences for more accurate and safe use |
| 03/13/2001 | US6200792 For bread- or dough-improving composition; reduction in bitter taste of protein hydrolyzates |
| 03/13/2001 | US6200787 Phenylalanyl tRNA synthetase polypeptides from streptococcus pneumoniae |
| 03/13/2001 | US6200786 From valencene |
| 03/13/2001 | US6200785 L-lysine-producing corynebacteria and process for the preparation of l-lysine |
| 03/13/2001 | US6200779 Nucleotide sequences which code protein associated with bacterial infection; for prevent of infections and associated defects |
| 03/13/2001 | US6200777 Human p101 polynucleotides |
| 03/13/2001 | US6200775 Nucleotide sequence coding a polypeptide associated with the diagnosis and treatment of infections |
| 03/13/2001 | US6200774 Compounds |
| 03/13/2001 | US6200578 Genetic engineered polypeptide |
| 03/13/2001 | CA1341203C Eukaryotic fusion proteins, containing interleukin-2 sequences |
| 03/11/2001 | CA2317058A1 New nucleotide sequences which code for the dapf gene |
| 03/08/2001 | WO2001016345A2 Sequence-specific dna recombination in eukaryotic cells |
| 03/08/2001 | WO2001016331A1 Cell-specific and/or tumor-specific promoter retargeting of herpes gamma 34.5 gene expression |
| 03/08/2001 | WO2001016327A2 Method for producing a channel-forming protein |
| 03/08/2001 | WO2001016319A2 Compositions and methods for the treatment of immune related diseases |
| 03/08/2001 | WO2001016308A2 Plant sterol acyltransferases |
| 03/08/2001 | WO2001016303A2 Nucleic acids which code for the enzyme activities of the spinosyn biosynthesis |
| 03/08/2001 | WO2001016302A1 Novel thermostable collagen-digesting enzyme, novel microorganism producing the enzyme and process for producing the enzyme |
| 03/08/2001 | WO2001016294A2 Metal binding compounds and their use in cell culture medium compositions |
| 03/08/2001 | WO2000068396A3 Bacillus circulans xylanase mutants |
| 03/08/2001 | WO2000058475A3 Streptococcus pneumoniae antigens |
| 03/08/2001 | WO2000049137A3 Pluripotential cell derived from an embryonic stem cell and a nucleus of a somatic cell |
| 03/08/2001 | WO2000018961A3 Expression analysis of specific nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer |
| 03/08/2001 | WO2000012736A9 A new method of identifying non-host plant disease resistance genes |
| 03/08/2001 | WO1999020723A8 Multiply-substituted protease variant and amylase variant-containing cleaning compositions |
| 03/08/2001 | DE19941478A1 Neue für das thrE-Gen codierende Nukleotidsequenzen und Verfahren zur fermentativen Herstellung von L-Threonin mit coryneformen Bakterien New coding for the thrE gene nucleotide sequences and processes for the fermentative preparation of L-threonine with coryneform bacteria |
| 03/08/2001 | CA2384055A1 Compositions and methods for the treatment of immune related diseases |
| 03/08/2001 | CA2383460A1 Metal binding compounds and their use in cell culture medium compositions |
| 03/08/2001 | CA2381901A1 A plant lecithin:cholesterol acyltransferase-like polypeptide |
| 03/08/2001 | CA2381139A1 Method for the production of a channel forming protein |
| 03/08/2001 | CA2380355A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/08/2001 | CA2317893A1 Production of natural flavors by laccase catalysis |
| 03/07/2001 | EP1081230A2 Process for producing N-acetyl-neuraminic acid |
| 03/07/2001 | EP1081099A1 Bioremediation process using bacterivorous protozoa |
| 03/07/2001 | EP1080220A1 New biotechnological process for preparing hydroxylated ml-236b derivatives, known as m-4 and m-4', and analogues thereof |
| 03/07/2001 | EP1080211A1 Method of producing thy-a-deficient strains of vibrio cholerae, such strains and their use |
| 03/07/2001 | EP1080188A2 Human nucleic acid sequences of uterus myoma tissue |
| 03/07/2001 | EP1080057A1 Genes encoding epsilon lycopene cyclase and method for producing bicyclic epsilon carotene |
| 03/07/2001 | EP0486526B2 Tumour necrosis factor binding ligands |
| 03/07/2001 | CN1286724A Bleaching compositions comprising multiply-substd, protease variants |
| 03/07/2001 | CN1286723A Cleaning compositions contg. multiply-substd-protease variants |
| 03/07/2001 | CN1286308A Method for producing N-acetylneuraminic acid |
| 03/07/2001 | CN1286307A Fermentation method for obtaining natural aromatic carboxylic acid, aliphatic carboxylic acid and thiocarbocylic acid, and microbe therefor |
| 03/07/2001 | CN1062908C Polypeptides and DNAs encoding them |
| 03/07/2001 | CN1062905C Enzyme with acetyl esterase activity |
| 03/07/2001 | CN1062904C 限制性核酸内切酶 Endonuclease restriction endonuclease |
| 03/07/2001 | CN1062903C New cephalosporin C acylase |
| 03/06/2001 | US6197939 Polypeptide regulator; for use as a diagnostic tool in detection of tumors |
| 03/06/2001 | US6197937 Antibody which preferentially binds mammalian binding protein; for the treatment of atherosclerosis |
| 03/06/2001 | US6197931 Human marco scavenger receptor |
| 03/06/2001 | US6197929 Bacterial polypeptide for use in prevention of bacterial infection |
| 03/06/2001 | US6197925 NF-AT polypeptides and polynucleotides |
| 03/06/2001 | US6197755 Compositions and methods for delivery of genetic material |
| 03/06/2001 | US6197754 Tyrosine kinase inhibitor |
| 03/06/2001 | US6197747 Insertion of the Bacillus thuringiensis crystal protein gene into plant colonizing microorganisms and their use |
| 03/06/2001 | US6197591 Nucleotide sequence which control the transcription of a preferential antibiotic |
| 03/06/2001 | US6197585 Producing neuronal tissues; immortalizing neuronal stem cells tissues, culturing tissues, terminating immortalization and allowing differentiation into brain tissues |